Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2019 to Oct 2024
Affymetrix to Webcast Presentation at UBS Warburg Conference
SANTA CLARA, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Affymetrix, Inc.
(NASDAQ:AFFX) today announced that it will webcast its presentation from the
UBS Warburg Global Life Sciences Conference in New York City. Greg Schiffman,
senior vice president and chief financial officer, will provide a Company
overview at 2:00 p.m. ET on Wednesday, September 29th.
An audio transmission of the presentation will be available live and by replay.
To access both the live and archived webcast, please go to
http://www.affymetrix.com/ and click on the "Investors" link. The archived
replay will be available at approximately 5:00 p.m. ET on September 29th and
will be available for seven days.
About Affymetrix
Affymetrix is a pioneer in creating breakthrough tools that are driving the
genomic revolution. By applying the principles of semiconductor technology to
the life sciences, Affymetrix develops and commercializes systems that enable
scientists to improve the quality of life. The Company's customers include
pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products
companies, as well as academic, government, and other non-profit research
institutes. Affymetrix offers an expanding portfolio of integrated products and
services, including its integrated GeneChip(R) brand platform to address the
growing markets focused on understanding the relationship between genes and
human health. Additional information on Affymetrix may be found at
http://www.affymetrix.com/.
DATASOURCE: Affymetrix, Inc.
CONTACT: Doug Farrell, Vice President of Investor Relations of
Affymetrix, Inc., +1-408-731-5285
Web site: http://www.affymetrix.com/